| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4075348
[patent_doc_number] => 05965606
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-12
[patent_title] => 'Methods of treatment with compounds having RAR.sub..alpha. receptor specific or selective activity'
[patent_app_type] => 1
[patent_app_number] => 8/580553
[patent_app_country] => US
[patent_app_date] => 1995-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 26413
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/965/05965606.pdf
[firstpage_image] =>[orig_patent_app_number] => 580553
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/580553 | Methods of treatment with compounds having RAR.sub..alpha. receptor specific or selective activity | Dec 28, 1995 | Issued |
| 08/578715 | AGENT FOR TREATING URINARY OUTLET OBSTRUCTION ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA | Dec 28, 1995 | Abandoned |
| 08/573811 | TREATMENT OF ACUTE LEUKEMIA WITH INTERLEUKIN-10 | Dec 17, 1995 | Abandoned |
Array
(
[id] => 3732138
[patent_doc_number] => 05665711
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Antitumor composition for oral administration'
[patent_app_type] => 1
[patent_app_number] => 8/570978
[patent_app_country] => US
[patent_app_date] => 1995-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4408
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665711.pdf
[firstpage_image] =>[orig_patent_app_number] => 570978
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/570978 | Antitumor composition for oral administration | Dec 11, 1995 | Issued |
Array
(
[id] => 3733159
[patent_doc_number] => 05665780
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Reversal of multi-drug resistance by tetraarylethylenes'
[patent_app_type] => 1
[patent_app_number] => 8/568067
[patent_app_country] => US
[patent_app_date] => 1995-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3082
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665780.pdf
[firstpage_image] =>[orig_patent_app_number] => 568067
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/568067 | Reversal of multi-drug resistance by tetraarylethylenes | Dec 5, 1995 | Issued |
Array
(
[id] => 3626276
[patent_doc_number] => 05621001
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Methods for administration of taxol'
[patent_app_type] => 1
[patent_app_number] => 8/559890
[patent_app_country] => US
[patent_app_date] => 1995-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7684
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/621/05621001.pdf
[firstpage_image] =>[orig_patent_app_number] => 559890
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/559890 | Methods for administration of taxol | Nov 19, 1995 | Issued |
| 08/560862 | EPINEPHRINE AS INHIBITOR OF CANCEROUS TUMORS | Nov 19, 1995 | Abandoned |
| 08/560626 | COMPONDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS: USE IN MEDICAL THERAPY AND DIAGNOSIS | Nov 19, 1995 | Abandoned |
| 08/554935 | CARCINOSTATIC SUBSTANCE FOR COMPATIBLE ADMINISTRATION, PROCESS OF ADMINISTRATING SAME AND PROCESS OF RAPIDLY INSPECTING SAME | Nov 8, 1995 | Abandoned |
Array
(
[id] => 3992343
[patent_doc_number] => 05891864
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Anti-cancer compositions'
[patent_app_type] => 1
[patent_app_number] => 8/552615
[patent_app_country] => US
[patent_app_date] => 1995-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 59
[patent_no_of_words] => 9149
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891864.pdf
[firstpage_image] =>[orig_patent_app_number] => 552615
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/552615 | Anti-cancer compositions | Nov 2, 1995 | Issued |
Array
(
[id] => 3809106
[patent_doc_number] => 05709853
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-20
[patent_title] => 'Method of treatment of atopic disease'
[patent_app_type] => 1
[patent_app_number] => 8/525755
[patent_app_country] => US
[patent_app_date] => 1995-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1534
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/709/05709853.pdf
[firstpage_image] =>[orig_patent_app_number] => 525755
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/525755 | Method of treatment of atopic disease | Nov 2, 1995 | Issued |
Array
(
[id] => 4201721
[patent_doc_number] => 06077545
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-20
[patent_title] => 'Process and composition for therapeutic cisplatin (CDDP)'
[patent_app_type] => 1
[patent_app_number] => 8/550086
[patent_app_country] => US
[patent_app_date] => 1995-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4984
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/077/06077545.pdf
[firstpage_image] =>[orig_patent_app_number] => 550086
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/550086 | Process and composition for therapeutic cisplatin (CDDP) | Oct 29, 1995 | Issued |
Array
(
[id] => 3872707
[patent_doc_number] => 05763488
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-09
[patent_title] => 'Methods and compositions using butyrate esters of threitol'
[patent_app_type] => 1
[patent_app_number] => 8/550453
[patent_app_country] => US
[patent_app_date] => 1995-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4304
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/763/05763488.pdf
[firstpage_image] =>[orig_patent_app_number] => 550453
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/550453 | Methods and compositions using butyrate esters of threitol | Oct 29, 1995 | Issued |
Array
(
[id] => 3621996
[patent_doc_number] => 05641803
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-24
[patent_title] => 'Methods for administration of taxol'
[patent_app_type] => 1
[patent_app_number] => 8/544594
[patent_app_country] => US
[patent_app_date] => 1995-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7680
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/641/05641803.pdf
[firstpage_image] =>[orig_patent_app_number] => 544594
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/544594 | Methods for administration of taxol | Oct 17, 1995 | Issued |
| 08/544642 | ANTIBOTIC STALOBACINS | Oct 17, 1995 | Abandoned |
| 08/464768 | CANCER TREATMENT AND METASTASIS PREVENTION | Oct 12, 1995 | Abandoned |
Array
(
[id] => 3729033
[patent_doc_number] => 05652234
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => '3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as antitumor agent'
[patent_app_type] => 1
[patent_app_number] => 8/513803
[patent_app_country] => US
[patent_app_date] => 1995-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5479
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/652/05652234.pdf
[firstpage_image] =>[orig_patent_app_number] => 513803
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/513803 | 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as antitumor agent | Oct 5, 1995 | Issued |
Array
(
[id] => 3695854
[patent_doc_number] => 05618830
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-08
[patent_title] => 'Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease'
[patent_app_type] => 1
[patent_app_number] => 8/536294
[patent_app_country] => US
[patent_app_date] => 1995-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7037
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/618/05618830.pdf
[firstpage_image] =>[orig_patent_app_number] => 536294
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/536294 | Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease | Sep 28, 1995 | Issued |
| 08/537170 | METHOD OF TREATING CANCER BY CONJUNCTIVE THERAPY WITH 2'-HALOMETHYLIDENE DERIVATIVES AND A S-PHASE OR M-PHASE SPECIFIC ANTINEOPLASTIC AGENT | Sep 27, 1995 | Abandoned |
| 08/533424 | 1,2,4-BENZOTRIAZINE OXIDES FORMULATIONS | Sep 24, 1995 | Abandoned |